Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- Allimax Nutraceuticals US starts clinical trial for treating Lyme disease
Allimax Nutraceuticals US, in conjunction with the Health Healing and Hope Foundation, have started their Lyme disease double blind clinical study being conducted in Texas by Dr.’s Joan Vandergriff ND, Hamid Moayad DO, William Keller Ph.D., Hugo Rodier M.D.
- Allimax Nutraceuticals US starts clinical trial for treating Lyme disease
Allimax Nutraceuticals US, in conjunction with the Health Healing and Hope Foundation, have started their Lyme disease double blind clinical study being conducted in Texas by Dr.’s Joan Vandergriff ND, Hamid Moayad DO, William Keller Ph.D., Hugo Rodier M.D.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Indian Food Safety and Standards Bill 2005 signed into law.
GCI Nutrients-India reports that the Indian Food Safety and Standards Bill 2005 was recently signed into law by the President of India.
- Indian Food Safety and Standards Bill 2005 signed into law.
GCI Nutrients-India reports that the Indian Food Safety and Standards Bill 2005 was recently signed into law by the President of India.
- NHPD October 2006 Monthly Communiqué Available
The NHPD Monthly Communiqué, October 2006 (Vol. 2, Issue 2), is now available online.
- NHPD October 2006 Monthly Communiqué Available
The NHPD Monthly Communiqué, October 2006 (Vol. 2, Issue 2), is now available online.
- NHPD October 2006 Monthly Communiqué Available
The NHPD Monthly Communiqué, October 2006 (Vol. 2, Issue 2), is now available online.
- Talks Ongoing: Trans-Tasman regulatory scheme
A second phase of consultation on the proposed trans-Tasman regulatory scheme for therapeutic products is now underway and feedback is being invited.
- Talks Ongoing: Trans-Tasman regulatory scheme
A second phase of consultation on the proposed trans-Tasman regulatory scheme for therapeutic products is now underway and feedback is being invited.
- United Natural Products Alliance (UNPA) Statement On The Status of Federal Dietary Supplement Serious Adverse Event Reporting Legislation
UNPA will continue to work aggressively for passage of the Non-Prescription Drug and Dietary Supplement Consumer Protection Act (S.3546/H.R.6168) when the Congress reconvenes for a brief “lame duck” session the week after the November elections.
- United Natural Products Alliance (UNPA) Statement On The Status of Federal Dietary Supplement Serious Adverse Event Reporting Legislation
UNPA will continue to work aggressively for passage of the Non-Prescription Drug and Dietary Supplement Consumer Protection Act (S.3546/H.R.6168) when the Congress reconvenes for a brief “lame duck” session the week after the November elections.
- United Natural Products Alliance (UNPA) Statement On The Status of Federal Dietary Supplement Serious Adverse Event Reporting Legislation
UNPA will continue to work aggressively for passage of the Non-Prescription Drug and Dietary Supplement Consumer Protection Act (S.3546/H.R.6168) when the Congress reconvenes for a brief “lame duck” session the week after the November elections.
- United Natural Products Alliance (UNPA) Statement On The Status of Federal Dietary Supplement Serious Adverse Event Reporting Legislation
UNPA will continue to work aggressively for passage of the Non-Prescription Drug and Dietary Supplement Consumer Protection Act (S.3546/H.R.6168) when the Congress reconvenes for a brief “lame duck” session the week after the November elections.
- Plant sterols and formulated beverages now approved
New standards allow Australians and New Zealanders to have access to a range of foods enriched with plant sterols, and allow manufacturers to make formulated beverages in Australia, not just New Zealand.
- Plant sterols and formulated beverages now approved
New standards allow Australians and New Zealanders to have access to a range of foods enriched with plant sterols, and allow manufacturers to make formulated beverages in Australia, not just New Zealand.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- SelenoExcell® Receives Independent GRAS Evaluation
Company has received independent GRAS designation for its flagship product SelenoExcell® High Selenium Yeast use in several food categories.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- FDA Approves Special Green Tea Extract as a New Topical Drug for Genital Warts
Last week the U.S. Food and Drug Administration (FDA) approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV). The new drug, called Veregen™ (Polyphenon® E) Ointment is the first prescription botanical (herbal) drug approved by FDA under the “new” drug amendments of 1962 that required drugs to be proven both safe and effective prior to being marketed in the U.S.
- McGuinty Government Regulates Traditional Chinese Medicine
Legislation in the province of Ontario regulating the practice of traditional Chinese medicine (TCM) has passed third and final reading and will become law once it receives Royal Assent.
- McGuinty Government Regulates Traditional Chinese Medicine
Legislation in the province of Ontario regulating the practice of traditional Chinese medicine (TCM) has passed third and final reading and will become law once it receives Royal Assent.
- McGuinty Government Regulates Traditional Chinese Medicine
Legislation in the province of Ontario regulating the practice of traditional Chinese medicine (TCM) has passed third and final reading and will become law once it receives Royal Assent.
- Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference
The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue.
- Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference
The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue.
- Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference
The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue.
- Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference
The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue.
- FTC Targets Bogus Claims for Pill Advertised to Make Kids Taller
A Florida business and its owner, who marketed purported height-enhancing pills for kids and young adults, will pay $375,000 to settle charges that their advertising claims were deceptive.
- FTC Targets Bogus Claims for Pill Advertised to Make Kids Taller
A Florida business and its owner, who marketed purported height-enhancing pills for kids and young adults, will pay $375,000 to settle charges that their advertising claims were deceptive.
- GMA/FPA Testifies Before U.S. Food & Drug Administration Public Hearing on Functional Foods
statement from Senior Vice President and Chief Science Officer Pat Verduin, Ph.D.: ""All conventional foods and beverages are functional and have functional ingredients. We believe there is no value in having a separate and distinct regulatory approach for some foods versus others. Furthermore, current statutory and regulatory provisions require that ingredients used in the formulation of any food -- including those that bear health, or structure- function claims -- must be approved food additives, or Generally Recognized as Safe (GRAS), for the intended use. This would include any novel or unique ingredients being incorporated into foods for functional benefits."
- GMA/FPA Testifies Before U.S. Food & Drug Administration Public Hearing on Functional Foods
statement from Senior Vice President and Chief Science Officer Pat Verduin, Ph.D.: ""All conventional foods and beverages are functional and have functional ingredients. We believe there is no value in having a separate and distinct regulatory approach for some foods versus others. Furthermore, current statutory and regulatory provisions require that ingredients used in the formulation of any food -- including those that bear health, or structure- function claims -- must be approved food additives, or Generally Recognized as Safe (GRAS), for the intended use. This would include any novel or unique ingredients being incorporated into foods for functional benefits."
- GMA/FPA Testifies Before U.S. Food & Drug Administration Public Hearing on Functional Foods
statement from Senior Vice President and Chief Science Officer Pat Verduin, Ph.D.: ""All conventional foods and beverages are functional and have functional ingredients. We believe there is no value in having a separate and distinct regulatory approach for some foods versus others. Furthermore, current statutory and regulatory provisions require that ingredients used in the formulation of any food -- including those that bear health, or structure- function claims -- must be approved food additives, or Generally Recognized as Safe (GRAS), for the intended use. This would include any novel or unique ingredients being incorporated into foods for functional benefits."
- GMA/FPA Testifies Before U.S. Food & Drug Administration Public Hearing on Functional Foods
statement from Senior Vice President and Chief Science Officer Pat Verduin, Ph.D.: ""All conventional foods and beverages are functional and have functional ingredients. We believe there is no value in having a separate and distinct regulatory approach for some foods versus others. Furthermore, current statutory and regulatory provisions require that ingredients used in the formulation of any food -- including those that bear health, or structure- function claims -- must be approved food additives, or Generally Recognized as Safe (GRAS), for the intended use. This would include any novel or unique ingredients being incorporated into foods for functional benefits."
- GMA/FPA Testifies Before U.S. Food & Drug Administration Public Hearing on Functional Foods
statement from Senior Vice President and Chief Science Officer Pat Verduin, Ph.D.: ""All conventional foods and beverages are functional and have functional ingredients. We believe there is no value in having a separate and distinct regulatory approach for some foods versus others. Furthermore, current statutory and regulatory provisions require that ingredients used in the formulation of any food -- including those that bear health, or structure- function claims -- must be approved food additives, or Generally Recognized as Safe (GRAS), for the intended use. This would include any novel or unique ingredients being incorporated into foods for functional benefits."
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- AHPA Tells FDA: No Need for Separate "Functional Foods" Rules
Noting that the Food and Drug Administration (FDA) already has full authority to ensure that foods and food ingredients are safe, the American Herbal Products Association (AHPA) today stated that additional regulations for so-called "functional foods" are not needed.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
OTTAWA, Nov. 2 /CNW Telbec/ - Health Canada is advising consumers not to
use four unauthorized natural health products that are promoted to treat
serious health conditions such as cancer, arthritis and heart disease because
such unapproved health claims are in violation of the Food and Drugs Act.
These unproven health claims may mislead patients to use the unauthorized
products in place of proven, approved treatment.
Although these products - Ellagimax capsules, Coral Max capsules, Coral
Max without Iron capsules, and Advanced Arthritis Support capsules - are
labelled as dietary supplements, they are being promoted with claims typically
associated with drug products. These claims are evident in the products'
labelling and promotional material. The safety and effectiveness of these
products have not been proven.
Ellagimax, Coral Max, Coral Max without Iron and Advanced Arthritis
Support capsules are distributed by Advantage Nutraceuticals L.L.C. of Fort
Walton Beach, Florida. They are not authorized for sale in Canada and have not
been found in the Canadian marketplace. However, the products have been sold
over the Internet and may also have been brought into Canada for personal use
by travellers.
Health Canada also advises Canadians to contact the Health Products and
Food Branch Inspectorate at 1-800-267-9675 if they find any of these four
products for sale in Canada. Health Canada has notified Customs officials to
be on the lookout for these products.
Canadians who have used any of these products and are concerned about
their health should contact a health care practitioner for advice. To date, no
adverse reactions suspected to be associated with the use of these four
products have been reported to Health Canada.
Consumers requiring more information about this advisory can contact the
Health Canada public inquiries line at (613) 957-2991, or toll free at
1-866-225-0709.
To report a suspected adverse reaction to these or any other health
products, please contact the Canadian Adverse Drug Reaction Monitoring Program
(CADRMP) of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
CADRMP
Marketed Health Products Directorate
Tunney's Pasture, AL 0701C
email: cadrmp@hc-sc.gc.ca
The CADRMP adverse reaction reporting form, including a version that can
be completed and submitted online, is located on the MedEffect portal
(www.medeffect.gc.ca) of the Health Canada Web site.
Egalement disponible en français
For further information: Media Inquiries: Health Canada, (613) 957-2983;
Public Inquiries: (613) 957-2991, 1-866-225-0
|